On August 30, 2024, Treasure Global Inc (the “Company”) accepted the resignations of Joseph “Bobby” Banks and Jeremy Roberts as members of the Board of Directors of the Company effective as of August 30, 2024.
Blink Charging Co. (the “Company”) is reporting that Brendan Jones, the Company’s President and Chief Executive Officer, informed the Board of Directors of the Company (the “Board”) on August 27, 2024, that he will step down from his role as the Company’s President and Chief Executive Officer and will retire from the Company effective January 31, 2025.
Departed
Laurence Hicks
director
Arch Therapeutics, Inc.
Effective
2024-08-28
Filed
August 30, 2024, 7:59 PM ET
On August 28, 2024, Laurence Hicks notified the board of directors (the “Board”) of Arch Therapeutics, Inc. (the “Company”) that he will resign as a member of the Board effective August 28, 2024.
Departed
Lisa Embree
Chief Financial Officer, Executive Vice President, Treasurer and Secretary
On August 28, 2024, Kurston P. McMurray, Executive Vice President and General Counsel and Secretary, notified NGL Energy Partners LP (the “Partnership”) that he will be resigning from his position with the Partnership effective October 2, 2024 to pursue other interests.
On August 26, 2024, Dr. Julius Few notified the board of directors (the "Board") of The Beauty Health Company (the "Company") of his decision to resign as a director of the Company, effective immediately.
Departed
Theresa Neri Strong
Chief Accounting Officer
Sterling Check Corp.
Effective
2024-08-28
Filed
August 30, 2024, 7:59 PM ET
Effective as of August 28, 2024, Theresa Neri Strong, Chief Accounting Officer of Sterling Check Corp. (the “Company”), went on maternity leave.
On August 29, 2024, the Board of Directors of Constellation Brands, Inc. (the “Company”) accepted the resignation of Judy A. Schmeling as a member of its Board of Directors, effective immediately.
The Company and Jim Gurnee, the current Vice President of Distribution, have mutually agreed to a separation date of September 30, 2024, to help provide a smooth transition in leadership of the Distribution Segment.
Mr. Morberg's separation will be treated as a termination by the Company without Cause subsequent to a Change in Control under that certain Executive Employment Agreement (the "Morberg Employment Agreement"), dated January 19, 2021, between the Company and Mr. Morberg
On August 28, 2024, Mr. Goldstein notified the Company that he will be retiring and resigning from his position as Executive Chairman of the Board effective as of September 10, 2024.
On August 27, 2024, Patricia D. Fili-Krushel communicated to the Board of Directors of the Company (the “Board”) her decision to resign from the Board, effective August 29, 2024.
Departed
Gary Williams
Vice President of Finance and Chief Accounting Officer
On August 23, 2024, Gary Williams, Vice President of Finance and Chief Accounting Officer (principal financial officer and principal accounting officer) of WiSA Technologies, Inc. (the “Company”), resigned, effective November 30, 2024 (the “Separation Date”).
George C. Freeman, III, who notified the Board of his retirement as Chairman, President and Chief Executive Officer and as a member of the Board on August 23, 2024, with such retirement effective October 1, 2024.
Dr. Eugene Scherbakov and Dr. Alexander Ovtchinnikov, previously disclosed as named executive officers of the Company, will not participate in the Revised AIP as a result of no longer being executive officers of the Company.
Dr. Eugene Scherbakov and Dr. Alexander Ovtchinnikov, previously disclosed as named executive officers of the Company, will not participate in the Revised AIP as a result of no longer being executive officers of the Company.
On August 23, 2024, Mr. Robert A. Bruggeworth notified the Board of Directors (the “Board”) of Seagate Technology Holdings, plc (the “Company”) that he has decided not to stand for re-election to the Board at the Company’s 2024 Annual General Meeting of Shareholders (the “Annual Meeting”).
Mr. Brian Di Donato notified Immunocore Holdings plc (the “Company”) of his decision to resign as Executive Vice President, Chief Financial Officer and Head of Strategy and principal financial officer of the Company, effective December 31, 2024, to pursue another opportunity.
On August 23, 2024 , Monica Sparks notified Banc of California, Inc. (the “Company”) and Banc of California (the “Bank”), a wholly owned subsidiary of the Company, of her decision to resign as Executive Vice President, Chief Accounting Officer of the Company and the Bank.
Departed
Michael Mason
Executive Vice President, Chief Financial Officer and Treasurer
On August 26, 2024, Michael Mason notified Karyopharm Therapeutics Inc. (the “Company”) of his intention to resign as the Company’s Executive Vice President, Chief Financial Officer and Treasurer to pursue other professional interests.
Departed
William E. Shea
Senior Vice President, Treasurer and Chief Financial Officer
On August 22, 2024, Shara Pathak resigned as a member of the Board of Directors of the registrant (“Laser Photonics”) without any disagreement regarding the operations, policies or practices of Laser Photonics.
On August 26, 2024, Charles R. Patton, a member of the Board of Directors (the “Board”) of Sterling Infrastructure, Inc. (the “Company”), notified the Company of his intention to retire from the Board and as a member of each of the Compensation and Talent Development Committee and the Corporate Governance and Nominating Committee, effective September 1, 2024.
On August 27, 2024, Hilliard M. Eure III resigned as a member of the Board of Directors (the “Board”) of MarineMax, Inc. (the “Company”), effective September 1, 2024.
Departed
Michael J. Berry
Executive Vice President and Chief Financial Officer
On August 22, 2024, Michael J. Berry informed the Company of his decision to transition from his role of Executive Vice President and Chief Financial Officer by May 23, 2025.
On August 26, 2024, David L. Lucchino, a member of our Board of Directors, or the Board, notified us that he resigned from the Board, effective immediately.
On August 28, 2024, the Company announced that Amy Weaver will step down from her role as President and Chief Financial Officer of the Company effective upon the appointment of her successor or upon the filing of the Company’s annual report on Form 10-K for the fiscal year ending January 31, 2025 (the “10-K Filing Date”), if earlier.
On August 28, 2024, the Company announced that effective as of August 28, 2024, Gregory S. Levin would no longer serve as the Company’s Chief Executive Officer and President or as a member of the Board.
On August 26, 2024, Melissa Goldman notified the Ally Financial Inc. ( Ally ) Board of Directors of her intention to resign as a director of Ally, effective on August 27, 2024.
Departed
Danelle Barrett
Director
ShoulderUP Technology Acquisition Corp.
Effective
2024-08-26
Filed
August 28, 2024, 7:59 PM ET
It is with deep sorrow that ShoulderUp Technology Acquisition Corp. (the “Company”) announces the unexpected passing of Danelle Barrett, a valued member of its Board of Directors, on August 26, 2024.
Departed
J. Tyler Opel
director
AmeriCann, Inc.
Effective
2024-08-23
Filed
August 28, 2024, 7:59 PM ET
On August 23, 2024 J. Tyler Opel stepped down as a director of the Company.
On August 26, 2024, Blake Johnson notified Two Harbors Investment Corp. (the “Company”) of his intention to resign from his position as Acting Chief Accounting Officer of the Company, effective no later than October 25, 2024
Jared Demark, having provided notice of his resignation, shall cease serving as chief executive officer (principal executive officer) of CoinShares Co. (the “Sponsor”).
Departed
Blaise Coleman
President and Chief Executive Officer
Endo LP
Effective
2024-08-29
Successor
Scott Hirsch
Filed
August 27, 2024, 7:59 PM ET
On August 25, 2024, the Board of Directors (the “Board”) of Endo, Inc. (the “Company”) determined that Blaise Coleman will no longer serve as the Company’s President and Chief Executive Officer, effective August 29, 2024.
Departed
Douglas S. Sharp
Executive Vice President of Finance, Chief Financial Officer and Treasurer
On August 21, 2024, Grace Johnston, Ph.D. delivered her resignation as the Chief Commercial Officer of Quantum-Si Incorporated (the “Company”), effective as of September 6, 2024.
Departed
Kristi Jones
Director
NexImmune, Inc.
Effective
2024-08-27
Successor
Craig Jalbert
Filed
August 27, 2024, 7:59 PM ET
On August 21, 2024, Sol J. Barer, Kristi Jones, Alan S. Roemer, Tim Bertram, Paul D’Angio, Grant Verstandig, Zhengbin (Bing) Yao and Leena Gandhi, each notified the Company of their respective resignations as members of the Company’s Board of Directors (the “Board”), effective as of August 27, 2024.
Departed
Kristi Jones
Chief Executive Officer
NexImmune, Inc.
Effective
2024-08-27
Successor
Craig Jalbert
Filed
August 27, 2024, 7:59 PM ET
The resignations of Kristi Jones, the Company’s Chief Executive Officer, Mathias Oelke, the Company’s Chief Scientific Officer, and Albert N. Marchio II, the Company’s Interim Chief Financial Officer and its principal financial and accounting officer from the Company were not due to any disagreements with the Company on any matters relating to the Company’s operations, policies or practices.
Departed
Leena Gandhi
Director
NexImmune, Inc.
Effective
2024-08-27
Successor
Craig Jalbert
Filed
August 27, 2024, 7:59 PM ET
On August 21, 2024, Sol J. Barer, Kristi Jones, Alan S. Roemer, Tim Bertram, Paul D’Angio, Grant Verstandig, Zhengbin (Bing) Yao and Leena Gandhi, each notified the Company of their respective resignations as members of the Company’s Board of Directors (the “Board”), effective as of August 27, 2024.
Departed
Sol J. Barer
Director
NexImmune, Inc.
Effective
2024-08-27
Successor
Craig Jalbert
Filed
August 27, 2024, 7:59 PM ET
On August 21, 2024, Sol J. Barer, Kristi Jones, Alan S. Roemer, Tim Bertram, Paul D’Angio, Grant Verstandig, Zhengbin (Bing) Yao and Leena Gandhi, each notified the Company of their respective resignations as members of the Company’s Board of Directors (the “Board”), effective as of August 27, 2024.
Departed
Alan S. Roemer
Director
NexImmune, Inc.
Effective
2024-08-27
Successor
Craig Jalbert
Filed
August 27, 2024, 7:59 PM ET
On August 21, 2024, Sol J. Barer, Kristi Jones, Alan S. Roemer, Tim Bertram, Paul D’Angio, Grant Verstandig, Zhengbin (Bing) Yao and Leena Gandhi, each notified the Company of their respective resignations as members of the Company’s Board of Directors (the “Board”), effective as of August 27, 2024.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.